Last reviewed 2026-04-19 · How we verify

Acromegaly

8 treatments

Approved treatments

Trovert · Pfizer
Pegvisomant works by binding to the growth hormone receptor, blocking the action of growth hormone and preventing excessive growth and cell division.
Somatuline Depot · Ipsen Pharma
Somatuline Depot works by mimicking the natural hormone somatostatin to block the production of excess growth hormone.
Parlodel · Esjay Pharma
Trovert · Pfizer
Lisurid
Lisuride works by binding to and activating the alpha-2A adrenergic receptor, which helps to regulate various physiological processes.
Palsonify · Crinetics
Palsonify works by binding to and inhibiting a specific protein involved in the regulation of growth hormone production.
Sandostatin · Novartis
Sandostatin works by mimicking the natural hormone somatostatin to inhibit the release of various hormones and growth factors.
Bromocriptin · University Hospital, Bonn

Competitive intelligence

For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:

Acromegaly patent landscape — cliff calendar, originator estates, attackable patents
Acromegaly treatment landscape brief
Acromegaly treatment updates RSS

Frequently asked questions about Acromegaly

What drugs treat Acromegaly?

Tracked treatments include Trovert, Somatuline Depot, Parlodel, Lisurid, Palsonify, Sandostatin, Bromocriptin.

What is the treatment for Acromegaly?

Standard treatment for Acromegaly includes Trovert, Somatuline Depot, Parlodel, Lisurid, Palsonify. See the treatment landscape page for first-line, second-line and salvage options.

Treatment landscape: Acromegaly patent cliff · Acromegaly CI report
Treatment: Trovert · Pfizer
Treatment: Somatuline Depot · Ipsen Pharma
Treatment: Parlodel · Esjay Pharma
Treatment: Trovert · Pfizer
Treatment: Lisurid
All diseases: Browse the disease index · Disease landscape hub

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing